Key result
Inflammatory markers were significantly elevated in patients with both alcoholic and non-alcoholic fatty liver disease compared to healthy controls, but showed no significant differences between the two fatty liver disease groups.
Why the study?
Differences in the level of increased circulating inflammatory markers between patients with AFLD and NAFLD remain unclear.
Cross-Sectional (n=105)
No
Absolute Event Rate: 7701.42% vs 7573.71%
p-value: p=>0.05
Fatty liver disease, whether alcoholic or non-alcoholic, is associated with similarly increased levels of inflammatory markers compared to healthy controls.
No difference in inflammatory markers between AFLD and NAFLD; leaves open shared mechanisms in larger prospective cohorts.
Background: Fatty liver disease has been associated with increased levels of various circulating inflammatory markers. Difference in the level of increased inflammatory markers between patients with AFLD and NAFLD is still unclear. Aim & Objectives: The aim of the present study was to compare the inflammatory markers between patients with alcoholic-fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD) and also to see if any correlation exists between inflammatory markers and liver enzymes. Materials & Methods: This study was conducted on 70 patients with fatty liver disease (35 AFLD and 35 NAFLD) and 35 healthy controls. Venous blood samples were taken and the required blood parameters (total leukocyte count, neutrophil count, lymphocyte count, ESR) and liver function test were determined. Statistical analysis was done by using Student’s t test and Pearson correlation test. Results: The TLC, Neutrophil count, N/L ratio and ESR were significantly higher while the lymphocyte count was significantly lower in patients with fatty liver disease when compared with the controls. The TLC, Neutrophil count, lymphocyte count, Neutrophil-lymphocyte ratio and ESR of patients with AFLD when compared to patients with NAFLD showed no statistically significant differences. There was a significant positive correlation between the value of ALT with TLC in patients with AFLD. Conclusion: Fatty liver disease is associated with increased inflammatory markers. Since increased inflammatory marker in fatty liver disease is indicative of liver injury, due importance should be given to assessment of inflammatory markers in the management of patients with fatty liver disease.
No takes yet. Share an insight, caveat, or question.
Devi et al. (2023) conducted a cross-sectional in Fatty liver disease (AFLD and NAFLD) (n=105). Alcoholic fatty liver disease (AFLD) vs. Non-alcoholic fatty liver disease (NAFLD) and healthy controls was evaluated on Total leukocyte count (cells/cumm) (p=>0.05). Inflammatory markers were significantly elevated in patients with both alcoholic and non-alcoholic fatty liver disease compared to healthy controls, but showed no significant differences between the two fatty liver disease groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: